National Medicines Regulatory Authority (NMRA) Sri Lanka

The National Medicines Regulatory Authority (NMRA), an independent authority in the Ministry of Health established in 2015 through an Act of Parliament. NMRA plays a leading role in protecting and improving public health by ensuring medicinal products available in the country meet applicable standards of safety, quality and efficacy. The Authority regulates medicines, medical devices, borderline products, clinical trials and cosmetics. The National Medicines Quality Assurance Laboratory (NMQAL), charged with ensuring the quality of medicinal products, also functions under the purview of the NMRA

Assessing the need of a medicinal product to be made available to the public,registration and licensing of medicines that meet applicable quality and safety standards and are cost-effective,providing guidance on classification of medicines,medical devices,borderline products and cosmetics,ensuring medicinal products are appropriately manufactured,stored,distributed and dispensed,regulating prices of medicinal products to ensure they are available to the general public at reasonable prices,registration and regulation of pharmacies to ensure they comply with good pharmacy practices,recommending appropriate amendments to relevant laws pertaining to regulation of medicinal products,ensuring promotion and adverting is fair,balanced and evidence-based,educating the general public on proper use of medicinal products,supporting post-marketing surveillance,regulating all matters pertaining to the conduct of clinical trials,and supporting initiatives for local manufacture of medicinal products

National medicines regulatory authority (nmra) sri lanka operates in the Government administration industry.

National medicines regulatory authority (nmra) sri lanka's revenue is 11m - 100m

National medicines regulatory authority (nmra) sri lanka has 51 - 200 employees.